drugset / Trial / NCT04746937
Nitazoxanide in Prevention of Secondary Spontaneous Peritonitis
RandomizedParallel-groupDouble-blindPrevention
Summary
the study is to evaluate the possible efficacy and safety of nitazoxanide as an adjuvant therapy in the secondary prevention of SBP in patient with cirrhosis.
Timeline
- Start
- 2021-03
- Primary completion
- 2022-03
- Completion
- 2022-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Nitazoxanide | Other / unclassified | — | — |
| Comparator | Norfloxacin | Small molecule | — | — |